Skip to main content
. 2022 May 17;24:34. doi: 10.1186/s13058-022-01529-9

Table 1.

Patient and tumour characteristics

Patients (N)
Total recruited 41
With PET data available 36
With PET and mRNA sequencing data available 31
Analysed 30
ER/HER2 status (N)
ER positive/negative 22/8
HER2 positive/negative 5/25
Triple negative (ER negative and HER2 negative) 8
Tumour type (N)
Ductal/lobular/mixed carcinoma 24/4/2
Grade 1/2/3 1/15/14
Characteristics of 30 patients analysed (median, range)
Age at study entry (years) 50 (34–67)
Tumour size on MRI scan (mm) 48 (30–118)
Body mass index 26.2 (19.6–44.9)